GeN is a drug discovery and pre-clinical validation biotechnology company with an innovative drug screening technology and a development-stage drug candidate.
PARTNER WITH US TO DEVELOP THE NEXT RARE DISEASE THERAPY
In ten years, we’ve delivered new treatments towards the clinic and FDA approved drugs. We develop partnerships to patent some of these treatments out and to the clinic-ready treatments with Neuren Pharmaceuticals, AMO Pharmaceuticals, Tetra Bio-Pharma and Ovid Pharmaceuticals.
Office 7 35-37 Ludgate Hill